This is an FDA approval action for a generic diazepam injectable formulation; it documents regulatory authorization, not clinical trial evidence or comparative efficacy.
Reported
Approval status date2026-07-27
Formulation strength10 mg/2 mL (5 mg/mL)
Route of administrationInjectable injection